Full Text Journal Articles in
Journal BMC Cancer

Advertisement

Find full text journal articles






Correlation between kidney transplantation and colorectal cancer in hemodialysis patients: A nationwide, retrospective, population-based cohort study.

Han-En Wang, Yu-Chan Liao, Je-Ming Hu, Wen-Chih Wu, Wan-Yun Chou, Yong-Chen Chen, Yu-Ching Chou, Chi-Feng Hung, Yu-Feng Tian, San-Lin You, Chien-An Sun,

BACKGROUND:Kidney transplantation (KT) correlates with an increased risk of developing several malignancies; however, the risk of colorectal cancer (CRC) after KT remains debatable and has been marginally explored. Hence, in this nationwide, retrospective, population-based cohort study, we aimed to examine the correlation between KT and CRC in a large-scale population-based ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1120]

Cited: 0 times

View full text PDF listing >>



A gene expression-based study on immune cell subtypes and glioma prognosis.

Qiu-Yue Zhong, Er-Xi Fan, Guang-Yong Feng, Qi-Ying Chen, Xiao-Xia Gou, Guo-Jun Yue, Gui-Hai Zhang,

OBJECT:Glioma is a common malignant tumours in the central nervous system (CNS), that exhibits high morbidity, a low cure rate, and a high recurrence rate. Currently, immune cells are increasingly known to play roles in the suppression of tumourigenesis, progression and tumour growth in many tumours. Therefore, given this increasing ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1116]

Cited: 0 times

View full text PDF listing >>



Advertisement

Correction to: Cinnamon extract induces tumor cell death through inhibition of NFκB and AP1.

Ho-Keun Kwon, Ji-Sun Hwang, Jae-Seon So, Choong-Gu Lee, Anupama Sahoo, Jae-Ha Ryu, Won Kyung Jeon, Byoung Seob Ko, Sung Haeng Lee, Zee Yong Park, Sin-Hyeog Im,

Following publication of the original article [1], the authors have re-evaluated the authorship for this article. The updated author group is. ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1113]

Cited: 0 times

View full text PDF listing >>



Frozen section accurately allows pathological characterization of endometrial cancer in patients with a preoperative ambiguous or inconclusive diagnoses: our experience.

A Santoro, A Piermattei, F Inzani, G Angelico, M Valente, D Arciuolo, S Spadola, M Martini, F Fanfani, A Fagotti, V Gallotta, G Scambia, G F Zannoni,

BACKGROUND:The aim of this study was to assess the agreement rate between intraoperative evaluation (IOE) and final diagnosis (FD) in a series of surgically resected endometrial carcinoma (EC), with a preoperative ambiguous or inconclusive diagnosis by endometrial biopsies and imaging. METHODS:A retrospective study was performed selecting patients who underwent surgery ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1096]

Cited: 0 times

View full text PDF listing >>



MiR-155 promotes anaplastic thyroid cancer progression by directly targeting SOCS1.

Wei Zhang, Wenyue Ji, Xudong Zhao,

BACKGROUND:Anaplastic thyroid cancer (ATC) is considered to be a rare type of thyroid cancer but takes up the most important proportion of thyroid cancer-related deaths. Therefore, the development of molecular targeted therapy is an exciting strategy in the management of ATC. METHODS:miR-155 and SOCS1 expression were measured by qRT-PCR as ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1093]

Cited: 0 times

View full text PDF listing >>



Advanced neoplasia in Veterans at screening colonoscopy using the National Cancer Institute Risk Assessment Tool.

Laura W Musselwhite, Thomas S Redding, Kellie J Sims, Meghan C O'Leary, Elizabeth R Hauser, Terry Hyslop, Ziad F Gellad, Brian A Sullivan, David Lieberman, Dawn Provenzale,

BACKGROUND:Adapting screening strategy to colorectal cancer (CRC) risk may improve efficiency for all stakeholders however limited tools for such risk stratification exist. Colorectal cancers usually evolve from advanced neoplasms that are present for years. We applied the National Cancer Institute (NCI) CRC Risk Assessment Tool, which calculates future risk of ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1097]

Cited: 0 times

View full text PDF listing >>



System-based approaches as prognostic tools for glioblastoma.

Manuela Salvucci, Zaitun Zakaria, Steven Carberry, Amanda Tivnan, Volker Seifert, Donat Kögel, Brona M Murphy, Jochen H M Prehn,

BACKGROUND:The evasion of apoptosis is a hallmark of cancer. Understanding this process holistically and overcoming apoptosis resistance is a goal of many research teams in order to develop better treatment options for cancer patients. Efforts are also ongoing to personalize the treatment of patients. Strategies to confirm the therapeutic efficacy ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1092]

Cited: 0 times

View full text PDF listing >>



Novel HDGF/HIF-1α/VEGF axis in oral cancer impacts disease prognosis.

Yu-Wei Lin, Shih-Tsung Huang, Jian-Ching Wu, Tian-Huei Chu, Shih-Chung Huang, Ching-Chih Lee, Ming-Hong Tai,

BACKGROUND:Hepatoma-derived growth factor (HDGF) participates in angiogenesis and represents a negative prognostic factor in oral cancer. The current study was designed to elucidate the regulatory mechanism between HDGF and vascular endothelial growth factor (VEGF) and the clinical impact of oral cancer. METHODS:TCGA data and surgical samples from oral cancer patients ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1083]

Cited: 0 times

View full text PDF listing >>



Ruxolitinib shows activity against Hodgkin lymphoma but not primary mediastinal large B-cell lymphoma.

Seok Jin Kim, Dok Hyun Yoon, Hye Jin Kang, Jung Yong Hong, Ho Sup Lee, Sung Yong Oh, Ho-Jin Shin, Jee Hyun Kong, Jun Ho Yi, Kana Sakamoto, Young Hyeh Ko, Jooryung Huh, Seung-Sook Lee, Kengo Takeuchi, Dong-Yeop Shin, Cheolwon Suh, Won Seog Kim,

BACKGROUND:The upregulated expression of the JAK/STAT pathway promotes tumor growth in Hodgkin lymphoma (HL) and primary mediastinal large B-cell lymphoma (PMBCL). Based on the hypothesis that JAK2 is a therapeutic target, we performed a prospective pilot study using ruxolitinib. METHODS:Relapsed or refractory patients with HL or PMBCL were eligible for ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1080]

Cited: 0 times

View full text PDF listing >>



Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.

Wei Yu, Chunxiu Hu, Yongjie Shui, Kui Wu, Lili Zhang, Ying Chen, Chao Li, Jing Xu, Qichun Wei,

BACKGROUND:To explore the patterns of failures and areas at highest risk of recurrence for postoperative intrahepatic cholangiocarcinoma (IHCC), with the aim to guide IHCC adjuvant radiotherapy. METHODS:Patients with IHCC who had undergone radical surgery at our institution from July 2010 to August 2017 were retrospectively analyzed. The survival and prognostic ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1108]

Cited: 0 times

View full text PDF listing >>



Silencing of long-non-coding RNA ANCR suppresses the migration and invasion of osteosarcoma cells by activating the p38MAPK signalling pathway.

Bo Liu, Hongyan Zhao, Lili Zhang, Xuefeng Shi,

BACKGROUND:Osteosarcoma (OS) is a malignancy of the bone that has no clearly identified prognostic factors for diagnosis. In this study, we evaluated the regulatory role of long non-coding RNA (lncRNA) ANCR on the migration and invasion of OS cells as well as the possible mechanism involving the p38MAPK signalling pathway. ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1112]

Cited: 0 times

View full text PDF listing >>



The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.

Chuchu Shao, Fengming Yang, Zhiqiang Qin, Xinming Jing, Yongqian Shu, Hua Shen,

BACKGROUND:Recently, a growing number of studies have reported the coorelation between miR-155 and the diagnosis and prognosis of lung cancer, but results of these researches were still controversial due to insufficient sample size. Thus, we carried out the systematic review and meta-analysis to figure out whether miR-155 could be a ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1103]

Cited: 0 times

View full text PDF listing >>



Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study.

Christina Boegh Jakobsen, Morten Lamberts, Nicholas Carlson, Morten Lock-Hansen, Christian Torp-Pedersen, Gunnar H Gislason, Morten Schou,

BACKGROUND:The prevalence of both atrial fibrillation (AF) and malignancies are increasing in the elderly, but incidences of new onset AF in different cancer subtypes are not well described.The objectives of this study were therefore to determine the incidence of AF in different cancer subtypes and to examine the association of ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1105]

Cited: 0 times

View full text PDF listing >>



Gastrointestinal stromal tumor with intracranial metastasis: case presentation and systematic review of literature.

Marc Prablek, Visish M Srinivasan, Aditya Srivatsan, Stephanie Holdener, Mazen Oneissi, Kent A Heck, Ali Jalali, Jacob Mandel, Ashwin Viswanathan, Akash J Patel,

BACKGROUND:Intracranial metastasis of Gastrointestinal Stromal Tumors (GISTs) is rare but presents unique treatment challenges. We present a case of intracranial metastasis of GIST with a systematic review of the literature. A literature search using key terms "'gastrointestinal stromal tumor' AND brain AND metastasis"" was conducted through May 2019 via Embase ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1119]

Cited: 0 times

View full text PDF listing >>



Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.

Semjon Willier, Karin Melanie Cabanillas Stanchi, Martina von Have, Vera Binder, Franziska Blaeschke, Judith Feucht, Tobias Feuchtinger, Michaela Döring,

BACKGROUND:Chemotherapy-induced nausea and vomiting (CINV) belong among the most burdensome side effects in hemato-oncology. Mostly, a combination of ondansetron and dexamethasone is used as antiemetic prophylaxis in pediatric patients undergoing emetogenic chemotherapy. However, dexamethasone is prohibited in different pediatric chemotherapy protocols. Currently, data on the use of ondansetron with the ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1118]

Cited: 0 times

View full text PDF listing >>



Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy.

Bo Zhao, Kun Cao, Xiao-Ting Li, Hai-Tao Zhu, Ying-Shi Sun,

BACKGROUND:The aim was to investigate the prognostic value of MR apparent diffusion coefficients (ADC) using histogram analysis (HA) in predicting disease-free survival (DFS) of cervical cancer after chemo-radiation therapy. METHODS:We retrospectively analyzed 103 women with pathologically proven squamous cell uterine cancer who received chemo-radiation therapy between 2009 and 2013. All ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1115]

Cited: 0 times

View full text PDF listing >>



ACRNaCT trial protocol: efficacy of adjuvant chemotherapy in patients with clinical T3b/T4, N+ rectal Cancer undergoing Neoadjuvant Chemoradiotherapy: a pathology-oriented, prospective, multicenter, randomized, open-label, parallel group clinical trial.

Qingguo Li, Dakui Luo, Ji Zhu, Lifeng Yang, Qi Liu, Yanlei Ma, Lei Liang, Sanjun Cai, Zhen Zhang, Xinxiang Li, ,

BACKGROUND:The CAO/ARO/AIO-94 demonstrated that neoadjuvant chemoradiotherapy (CRT) could decrease the rate of local recurrence rather than distal metastases in advanced rectal cancer. Adjuvant chemotherapy (ACT) can eliminate micrometastasis, and render a better prognosis to rectal cancer. However, adoption of ACT mainly depends on the evidence from colon cancer. Neoadjuvant CRT ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1117]

Cited: 0 times

View full text PDF listing >>



Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.

Zhensheng Li, Dongxing Shen, Jian Zhang, Jun Zhang, Fang Yang, Deyou Kong, Jie Kong, Andu Zhang,

BACKGROUND:The relationship between whole brain radiotherapy (WBRT) dose with intracranial tumor control and overall survival (OS) in patients with non-small cell lung cancer (NSCLC) brain metastases (BM) is largely unknown. METHODS:We retrospectively analyzed 595 NSCLC BM patients treated consecutively at the Fourth Hospital of Hebei Medical University between 2013 to ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1104]

Cited: 0 times

View full text PDF listing >>



PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.

Hannah L Buckley, Fiona J Collinson, Gemma Ainsworth, Heather Poad, Louise Flanagan, Eszter Katona, Helen C Howard, Geraldine Murden, Rosamonde E Banks, Joanne Brown, Galina Velikova, Tom Waddell, Kate Fife, Paul D Nathan, James Larkin, Thomas Powles, Sarah R Brown, Naveen S Vasudev,

BACKGROUND:The combination of nivolumab, a programmed death-1 (PD-1) targeted monoclonal antibody, with the cytotoxic T-lymphocyte antigen-4 (CTLA-4) targeted antibody, ipilimumab, represents a new standard of care in the first-line setting for patients with intermediate- and poor-risk metastatic renal cell carcinoma (mRCC) based on recent phase III data. Combining ipilimumab with ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1102]

Cited: 0 times

View full text PDF listing >>



Mapping of sentinel lymph node drainage using SPECT/CT to tailor elective nodal irradiation in head and neck cancer patients (SUSPECT-2): a single-center prospective trial.

Pieter D de Veij Mestdagh, Willem H Schreuder, Wouter V Vogel, Maarten L Donswijk, Eric van Werkhoven, Jacqueline E van der Wal, Richard Dirven, Baris Karakullukcu, Jan-Jakob Sonke, Michiel W M van den Brekel, Corrie A M Marijnen, Abrahim Al-Mamgani,

BACKGROUND:The majority of patients with head and neck squamous cell carcinoma (HNSCC) receive bilateral elective nodal irradiation (ENI), in order to reduce the risk of regional failure. Bilateral ENI, as compared to unilateral ENI, is associated with higher incidence of acute and late radiation-induced toxicity with subsequent deterioration of quality ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1110]

Cited: 0 times

View full text PDF listing >>



Circulating tumour DNA (ctDNA) as a biomarker in metachronous melanoma and colorectal cancer- a case report.

Leslie Calapre, Lydia Warburton, Michael Millward, Elin S Gray,

BACKGROUND:Circulating tumour DNA (ctDNA) has emerged as a promising blood-based biomarker for monitoring disease status of patients with advanced cancers. The presence of ctDNA in the blood is a result of biological processes, namely tumour cell apoptosis and/or necrosis, and can be used to monitor different cancers by targeting cancer-specific ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1109]

Cited: 0 times

View full text PDF listing >>



Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic review.

Jessa Gilda P Pandy, Joanmarie C Balolong-Garcia, Mel Valerie B Cruz-Ordinario, Frances Victoria F Que,

BACKGROUND:Triple negative breast cancer (TNBC) represents 15-20% of breast cancers. Due to its heterogeneity and high rates of relapse, there is a need to optimize treatment efficacy. Platinum chemotherapy is still controversial and currently not recommended as first-line treatment for TNBC. Recent studies have shown promising activity of this regimen. ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1065]

Cited: 0 times

View full text PDF listing >>



Current state of esophageal cancer surgery in China: a national database analysis.

Ming-Lian Qiu, Jian-Bo Lin, Xu Li, Rong-Gang Luo, Bo Liu, Jing-Wei Lin,

BACKGROUND:The present standard of surgical treatment for esophageal cancer is country dependent. The aim of the present study was to investigate the basic aspects of surgical procedures performed for esophageal cancer, and provide information about the present state of esophageal cancer surgery in China. METHODS:Data were obtained from a database ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1064]

Cited: 0 times

View full text PDF listing >>



Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.

Shigang Xiong, Paulette Mhawech-Fauceglia, Denice Tsao-Wei, Lynda Roman, Rajesh K Gaur, Alan L Epstein, Jacek Pinski,

We investigated the association of LHR expression in epithelial ovarian cancer (OC) with clinical and pathologic characteristics of patients. LHR expression was examined immunohistochemically using tissue microarrays (TMAs) of specimens from 232 OC patients. Each sample was scored quantitatively evaluating LHR staining intensity (LHR-I) and percentage of LHR (LHR-P) staining ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1114]

Cited: 0 times

View full text PDF listing >>



The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.

Ru Wang, Yayun Zhu, Xiaoxu Liu, Xiaoqin Liao, Jianjun He, Ligang Niu,

BACKGROUND:The features and survival of stage IV breast cancer patients with different metastatic sites are poorly understood. This study aims to examine the clinicopathological features and survival of stage IV breast cancer patients according to different metastatic sites. METHODS:Using the Surveillance, Epidemiology, and End Results database, we restricted our study ... Read more >>

BMC Cancer (BMC cancer)
[2019, 19(1):1091]

Cited: 0 times

View full text PDF listing >>



Advertisement

Disclaimer
1.53 s